said-on-friday
Fed’s Yellen faces battle in 2016 after getting all clear for December hike
December 5, 2015 by creative · Leave a Comment
WASHINGTON/PHILADELPHIA (Reuters) – Federal Reserve Chair Janet Yellen has the evidence of U.S. labor market health she wanted in order to raise benchmark interest rates for the first time in a decade this month, but she may have a tougher time selling further hikes. Federal funds futures contracts imply a 79-percent chance that the Fed will end seven years of near-zero interest rates at its December meeting and about even odds of a second rate rise by March. Interest rate futures …
Go here to see the original:
Fed’s Yellen faces battle in 2016 after getting all clear for December hike
said-on-friday
U.S. employment report a green light for Fed interest rate rise
December 5, 2015 by creative · Leave a Comment
By Lucia Mutikani WASHINGTON (Reuters) – U.S. employment increased at a healthy pace in November, in another sign of the economy's resilience, and will most likely be followed by the first Federal Reserve interest rate rise in a decade later this month. Nonfarm payrolls rose
Original post:
U.S. employment report a green light for Fed interest rate rise
said-on-friday
HSBC says to shut down India private banking business
November 27, 2015 by creative · Leave a Comment
HSBC Holdings Plc is shutting its private banking unit in India, marking the exit of another foreign bank from the cut-throat wealth management business in Asia's third-largest economy. “After a strategic review of the global private banking operations in India
Original post:
HSBC says to shut down India private banking business
said-on-friday
Exclusive: Pfizer, Allergan CEOs agree on combined company roles – sources
November 21, 2015 by elegant · Leave a Comment
Pfizer Inc and Allergan Inc chief executives have agreed on the roles they would assume in a combined company, removing one of the last hurdles to the largest ever healthcare merger, people familiar with the matter said. Pfizer CEO Ian Read will be CEO of the combined company, while Allergan CEO Brent Saunders will have another very senior role, the people said on Friday, without providing more details. Pfizer and Allergan declined to comment.
Original post:
Exclusive: Pfizer, Allergan CEOs agree on combined company roles – sources